| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Gastroenterology | 9 | 2024 | 571 | 1.370 |
Why?
|
| Education, Medical, Graduate | 7 | 2024 | 2363 | 1.190 |
Why?
|
| Celiac Disease | 10 | 2022 | 822 | 1.180 |
Why?
|
| Fellowships and Scholarships | 7 | 2024 | 1116 | 1.160 |
Why?
|
| Pediatrics | 9 | 2020 | 3586 | 0.850 |
Why?
|
| Hospitals, Pediatric | 2 | 2024 | 1854 | 0.780 |
Why?
|
| Curriculum | 4 | 2024 | 3718 | 0.760 |
Why?
|
| Faculty | 1 | 2024 | 383 | 0.720 |
Why?
|
| Duodenum | 4 | 2019 | 486 | 0.700 |
Why?
|
| Professional Competence | 2 | 2014 | 431 | 0.690 |
Why?
|
| Torture | 1 | 2020 | 66 | 0.670 |
Why?
|
| Faculty, Medical | 3 | 2024 | 1192 | 0.550 |
Why?
|
| Endoscopy, Digestive System | 2 | 2019 | 351 | 0.540 |
Why?
|
| Clinical Competence | 6 | 2020 | 4783 | 0.500 |
Why?
|
| Humanism | 1 | 2014 | 87 | 0.430 |
Why?
|
| Diet, Gluten-Free | 4 | 2022 | 280 | 0.400 |
Why?
|
| Hospitals, Teaching | 1 | 2016 | 1166 | 0.390 |
Why?
|
| Mentors | 1 | 2016 | 661 | 0.380 |
Why?
|
| Crohn Disease | 15 | 2014 | 2275 | 0.360 |
Why?
|
| Internship and Residency | 4 | 2024 | 5870 | 0.340 |
Why?
|
| Education, Medical | 2 | 2024 | 1727 | 0.330 |
Why?
|
| Colitis, Ulcerative | 15 | 2009 | 1919 | 0.290 |
Why?
|
| Tacrolimus | 3 | 2000 | 733 | 0.270 |
Why?
|
| Child | 54 | 2024 | 79799 | 0.270 |
Why?
|
| Academic Medical Centers | 3 | 2024 | 2754 | 0.200 |
Why?
|
| Colonoscopy | 4 | 2024 | 1387 | 0.200 |
Why?
|
| Hematology | 1 | 2024 | 241 | 0.180 |
Why?
|
| Constipation | 2 | 2016 | 561 | 0.180 |
Why?
|
| Needs Assessment | 2 | 2019 | 1139 | 0.180 |
Why?
|
| Reference Standards | 1 | 2024 | 1004 | 0.170 |
Why?
|
| Inflammatory Bowel Diseases | 8 | 2004 | 2421 | 0.170 |
Why?
|
| Vitamin A Deficiency | 2 | 1998 | 88 | 0.170 |
Why?
|
| National Socialism | 1 | 2020 | 54 | 0.170 |
Why?
|
| Child, Preschool | 35 | 2022 | 42056 | 0.170 |
Why?
|
| Biopsy | 8 | 2019 | 6771 | 0.170 |
Why?
|
| Sex Education | 1 | 2019 | 92 | 0.160 |
Why?
|
| House Calls | 1 | 2020 | 160 | 0.160 |
Why?
|
| Vitamin E Deficiency | 1 | 1998 | 30 | 0.150 |
Why?
|
| Lost to Follow-Up | 1 | 2018 | 123 | 0.150 |
Why?
|
| Immunosuppressive Agents | 3 | 2000 | 4167 | 0.140 |
Why?
|
| Humans | 84 | 2024 | 760613 | 0.140 |
Why?
|
| Autoimmune Diseases | 5 | 2014 | 2250 | 0.130 |
Why?
|
| Intestinal Mucosa | 6 | 2017 | 3022 | 0.130 |
Why?
|
| Aminosalicylic Acids | 1 | 1995 | 37 | 0.130 |
Why?
|
| Ileocecal Valve | 1 | 1995 | 21 | 0.130 |
Why?
|
| Transglutaminases | 1 | 2017 | 197 | 0.130 |
Why?
|
| Gastroscopy | 1 | 1997 | 209 | 0.120 |
Why?
|
| Diseases in Twins | 2 | 1995 | 447 | 0.120 |
Why?
|
| Immunoglobulin A | 3 | 2017 | 978 | 0.120 |
Why?
|
| Single-Blind Method | 1 | 2019 | 1578 | 0.120 |
Why?
|
| Ethics, Medical | 1 | 2020 | 783 | 0.120 |
Why?
|
| Fibroblast Growth Factor 2 | 1 | 1997 | 590 | 0.120 |
Why?
|
| Colitis | 4 | 1996 | 1229 | 0.120 |
Why?
|
| Pancreatin | 1 | 1994 | 9 | 0.120 |
Why?
|
| Immunologic Deficiency Syndromes | 1 | 2018 | 557 | 0.120 |
Why?
|
| Gastrostomy | 1 | 1997 | 321 | 0.110 |
Why?
|
| Adolescent | 42 | 2019 | 87809 | 0.110 |
Why?
|
| Esophagus | 4 | 1999 | 1023 | 0.110 |
Why?
|
| Adenomatous Polyposis Coli | 2 | 2009 | 218 | 0.110 |
Why?
|
| Nutrition Disorders | 1 | 1994 | 205 | 0.110 |
Why?
|
| Esophageal and Gastric Varices | 2 | 1995 | 208 | 0.110 |
Why?
|
| Proctocolectomy, Restorative | 2 | 2009 | 190 | 0.110 |
Why?
|
| Lymphocytosis | 2 | 2008 | 119 | 0.110 |
Why?
|
| Esophagoscopy | 1 | 1995 | 390 | 0.110 |
Why?
|
| Esophagitis | 2 | 1999 | 163 | 0.100 |
Why?
|
| Gastrointestinal Hemorrhage | 4 | 1998 | 1131 | 0.100 |
Why?
|
| GTP-Binding Proteins | 1 | 2017 | 951 | 0.100 |
Why?
|
| Stomach | 1 | 1996 | 694 | 0.100 |
Why?
|
| Receptors, LDL | 2 | 1984 | 488 | 0.100 |
Why?
|
| Intestinal Obstruction | 1 | 1995 | 434 | 0.100 |
Why?
|
| Intraoperative Care | 1 | 1995 | 768 | 0.100 |
Why?
|
| Autoimmunity | 2 | 2022 | 1370 | 0.100 |
Why?
|
| Continuity of Patient Care | 1 | 2018 | 1066 | 0.100 |
Why?
|
| Colon | 6 | 2008 | 1788 | 0.100 |
Why?
|
| Lipoproteins, LDL | 2 | 1984 | 641 | 0.090 |
Why?
|
| Teaching | 1 | 2019 | 1169 | 0.090 |
Why?
|
| Education, Medical, Continuing | 1 | 2016 | 830 | 0.090 |
Why?
|
| Female | 51 | 2024 | 391246 | 0.090 |
Why?
|
| Infant | 25 | 2017 | 36053 | 0.090 |
Why?
|
| Pancreaticoduodenectomy | 1 | 1994 | 508 | 0.090 |
Why?
|
| Enteritis | 2 | 2008 | 162 | 0.090 |
Why?
|
| Male | 44 | 2024 | 359718 | 0.090 |
Why?
|
| Cystic Fibrosis | 1 | 2019 | 1274 | 0.080 |
Why?
|
| Food Services | 1 | 2012 | 205 | 0.080 |
Why?
|
| Antacids | 2 | 2008 | 94 | 0.080 |
Why?
|
| Endoscopy | 2 | 2019 | 1838 | 0.080 |
Why?
|
| Endoscopy, Gastrointestinal | 1 | 1995 | 867 | 0.080 |
Why?
|
| Epidermolysis Bullosa, Junctional | 1 | 2008 | 12 | 0.080 |
Why?
|
| Integrin beta4 | 1 | 2008 | 31 | 0.080 |
Why?
|
| Intestinal Diseases | 2 | 2008 | 506 | 0.080 |
Why?
|
| Parturition | 1 | 2012 | 446 | 0.080 |
Why?
|
| Digestive System Abnormalities | 1 | 2008 | 49 | 0.080 |
Why?
|
| Pylorus | 1 | 2008 | 86 | 0.080 |
Why?
|
| Lymphocytes | 1 | 1996 | 2611 | 0.080 |
Why?
|
| Chi-Square Distribution | 2 | 2009 | 3465 | 0.080 |
Why?
|
| Program Evaluation | 1 | 2016 | 2493 | 0.080 |
Why?
|
| Colonic Pouches | 1 | 2009 | 122 | 0.080 |
Why?
|
| Anti-Ulcer Agents | 1 | 2008 | 113 | 0.080 |
Why?
|
| Boston | 2 | 2021 | 9278 | 0.070 |
Why?
|
| Gastrointestinal Diseases | 4 | 1998 | 1189 | 0.070 |
Why?
|
| Hepatitis, Chronic | 1 | 1987 | 52 | 0.070 |
Why?
|
| Cyclosporins | 1 | 1987 | 216 | 0.070 |
Why?
|
| T-Lymphocytes, Cytotoxic | 1 | 2014 | 1765 | 0.070 |
Why?
|
| Diarrhea | 4 | 2008 | 1319 | 0.070 |
Why?
|
| Checklist | 1 | 2014 | 827 | 0.070 |
Why?
|
| Universities | 1 | 2012 | 992 | 0.070 |
Why?
|
| Chilblains | 1 | 2006 | 16 | 0.070 |
Why?
|
| Prospective Studies | 9 | 2020 | 54306 | 0.070 |
Why?
|
| Predictive Value of Tests | 3 | 2019 | 15286 | 0.070 |
Why?
|
| Pancreatitis | 2 | 2003 | 1100 | 0.070 |
Why?
|
| Hydronephrosis | 1 | 1987 | 271 | 0.070 |
Why?
|
| Referral and Consultation | 2 | 2018 | 3598 | 0.070 |
Why?
|
| Sensitivity and Specificity | 3 | 2019 | 14661 | 0.060 |
Why?
|
| Wound Healing | 1 | 1997 | 2788 | 0.060 |
Why?
|
| Adult | 21 | 2024 | 220007 | 0.060 |
Why?
|
| Health Personnel | 1 | 2019 | 3310 | 0.060 |
Why?
|
| Ulcer | 2 | 1997 | 204 | 0.060 |
Why?
|
| Hexosephosphates | 1 | 1984 | 26 | 0.060 |
Why?
|
| Mannosephosphates | 1 | 1984 | 11 | 0.060 |
Why?
|
| Scoliosis | 1 | 1991 | 735 | 0.060 |
Why?
|
| Esophageal Diseases | 2 | 1996 | 168 | 0.060 |
Why?
|
| Remission Induction | 3 | 2000 | 2392 | 0.060 |
Why?
|
| Lovastatin | 1 | 1984 | 116 | 0.060 |
Why?
|
| Statistics, Nonparametric | 1 | 2009 | 2852 | 0.060 |
Why?
|
| Fruit | 2 | 1988 | 1160 | 0.050 |
Why?
|
| Procollagen | 3 | 1989 | 188 | 0.050 |
Why?
|
| Pirenzepine | 1 | 2003 | 116 | 0.050 |
Why?
|
| United States | 6 | 2024 | 72448 | 0.050 |
Why?
|
| L-Lactate Dehydrogenase | 1 | 2003 | 412 | 0.050 |
Why?
|
| Patient Compliance | 1 | 2012 | 2688 | 0.050 |
Why?
|
| Aspartate Aminotransferases | 1 | 2003 | 415 | 0.050 |
Why?
|
| Career Mobility | 1 | 2024 | 258 | 0.050 |
Why?
|
| Societies, Medical | 2 | 2013 | 3905 | 0.050 |
Why?
|
| Data Collection | 1 | 2010 | 3315 | 0.050 |
Why?
|
| Alanine Transaminase | 1 | 2003 | 607 | 0.050 |
Why?
|
| Valproic Acid | 1 | 2003 | 441 | 0.050 |
Why?
|
| Haploinsufficiency | 1 | 2022 | 329 | 0.040 |
Why?
|
| Endothelial Growth Factors | 2 | 2001 | 673 | 0.040 |
Why?
|
| Hepatocyte Growth Factor | 1 | 2001 | 267 | 0.040 |
Why?
|
| Blood Sedimentation | 2 | 1998 | 234 | 0.040 |
Why?
|
| Attitude of Health Personnel | 1 | 2014 | 3865 | 0.040 |
Why?
|
| Quality Improvement | 1 | 2015 | 3835 | 0.040 |
Why?
|
| Antimanic Agents | 1 | 2003 | 520 | 0.040 |
Why?
|
| Lymphokines | 2 | 2001 | 927 | 0.040 |
Why?
|
| Azathioprine | 1 | 2000 | 356 | 0.040 |
Why?
|
| Pharmaceutical Solutions | 1 | 1998 | 15 | 0.040 |
Why?
|
| Interdisciplinary Studies | 1 | 2019 | 86 | 0.040 |
Why?
|
| Glutens | 1 | 2021 | 240 | 0.040 |
Why?
|
| Competency-Based Education | 1 | 2020 | 218 | 0.040 |
Why?
|
| Primary Health Care | 1 | 2015 | 4647 | 0.040 |
Why?
|
| Carcinoma, Hepatocellular | 2 | 1996 | 2299 | 0.040 |
Why?
|
| Gangliosides | 1 | 1999 | 131 | 0.040 |
Why?
|
| Aluminum | 1 | 1998 | 152 | 0.040 |
Why?
|
| Complementary Therapies | 1 | 2002 | 486 | 0.040 |
Why?
|
| Immunologic Factors | 1 | 2007 | 1588 | 0.040 |
Why?
|
| Malabsorption Syndromes | 3 | 1988 | 135 | 0.040 |
Why?
|
| Sigmoidoscopy | 2 | 1996 | 150 | 0.040 |
Why?
|
| Reoperation | 3 | 1997 | 4289 | 0.040 |
Why?
|
| Parenteral Nutrition, Total | 1 | 1998 | 303 | 0.040 |
Why?
|
| Growth | 3 | 1989 | 365 | 0.040 |
Why?
|
| Proctitis | 1 | 1997 | 41 | 0.040 |
Why?
|
| Hepatitis B virus | 1 | 1981 | 522 | 0.040 |
Why?
|
| Drug Contamination | 1 | 1998 | 152 | 0.040 |
Why?
|
| Gastroscopes | 1 | 1997 | 19 | 0.040 |
Why?
|
| Duodenoscopy | 1 | 2017 | 45 | 0.040 |
Why?
|
| Accreditation | 1 | 2020 | 477 | 0.030 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 3 | 2001 | 3802 | 0.030 |
Why?
|
| Games, Experimental | 1 | 2016 | 32 | 0.030 |
Why?
|
| Retrospective Studies | 12 | 2021 | 80345 | 0.030 |
Why?
|
| Prenatal Exposure Delayed Effects | 1 | 2008 | 2496 | 0.030 |
Why?
|
| Physicians | 1 | 2014 | 4591 | 0.030 |
Why?
|
| Hypersensitivity | 2 | 2008 | 1155 | 0.030 |
Why?
|
| Intestines | 2 | 2008 | 1907 | 0.030 |
Why?
|
| Hepatitis B | 1 | 1981 | 701 | 0.030 |
Why?
|
| Ileal Diseases | 1 | 1995 | 69 | 0.030 |
Why?
|
| Schools, Medical | 1 | 2022 | 878 | 0.030 |
Why?
|
| Infant, Newborn | 8 | 2017 | 26179 | 0.030 |
Why?
|
| Arteriovenous Malformations | 1 | 1998 | 397 | 0.030 |
Why?
|
| Medical History Taking | 1 | 2019 | 773 | 0.030 |
Why?
|
| Stomach Diseases | 1 | 1996 | 133 | 0.030 |
Why?
|
| Liver Neoplasms | 2 | 1996 | 4319 | 0.030 |
Why?
|
| Young Adult | 6 | 2019 | 58748 | 0.030 |
Why?
|
| Cellulitis | 1 | 1997 | 207 | 0.030 |
Why?
|
| Receptors, Interleukin-2 | 1 | 1996 | 562 | 0.030 |
Why?
|
| Vitamin A | 1 | 1998 | 613 | 0.030 |
Why?
|
| Leadership | 1 | 2024 | 1371 | 0.030 |
Why?
|
| Liver Function Tests | 1 | 1996 | 524 | 0.030 |
Why?
|
| Liver Regeneration | 1 | 1996 | 213 | 0.030 |
Why?
|
| Siblings | 1 | 2018 | 824 | 0.030 |
Why?
|
| Xylose | 1 | 1994 | 28 | 0.030 |
Why?
|
| 4-Aminobenzoic Acid | 1 | 1994 | 22 | 0.030 |
Why?
|
| Hydroxycholecalciferols | 1 | 1994 | 44 | 0.030 |
Why?
|
| Catheters, Indwelling | 1 | 1997 | 428 | 0.030 |
Why?
|
| Equipment Failure | 1 | 1997 | 577 | 0.030 |
Why?
|
| Postoperative Complications | 3 | 1997 | 15679 | 0.030 |
Why?
|
| Ligation | 1 | 1995 | 448 | 0.030 |
Why?
|
| Odds Ratio | 3 | 2008 | 9716 | 0.030 |
Why?
|
| Gastric Emptying | 2 | 1994 | 243 | 0.030 |
Why?
|
| Sclerotherapy | 1 | 1995 | 181 | 0.030 |
Why?
|
| Vitamin E | 1 | 1998 | 872 | 0.030 |
Why?
|
| Gastroesophageal Reflux | 3 | 1999 | 816 | 0.030 |
Why?
|
| Laparotomy | 1 | 1995 | 465 | 0.030 |
Why?
|
| Hemangioma | 1 | 1998 | 728 | 0.030 |
Why?
|
| Eosinophilia | 2 | 1999 | 559 | 0.030 |
Why?
|
| Dimerization | 1 | 2014 | 891 | 0.030 |
Why?
|
| Chloroquine | 2 | 1984 | 277 | 0.030 |
Why?
|
| Growth Disorders | 2 | 1997 | 653 | 0.030 |
Why?
|
| Penetrance | 1 | 2014 | 388 | 0.030 |
Why?
|
| Intestinal Absorption | 1 | 1994 | 400 | 0.030 |
Why?
|
| Hepatectomy | 1 | 1996 | 559 | 0.030 |
Why?
|
| Prevalence | 1 | 2009 | 15686 | 0.030 |
Why?
|
| Registries | 1 | 2008 | 8458 | 0.030 |
Why?
|
| Milk Hypersensitivity | 1 | 1993 | 78 | 0.030 |
Why?
|
| Epithelium | 1 | 1996 | 1605 | 0.020 |
Why?
|
| Pedigree | 2 | 2014 | 4578 | 0.020 |
Why?
|
| Amylases | 1 | 1991 | 169 | 0.020 |
Why?
|
| Hydrogen-Ion Concentration | 3 | 1999 | 2502 | 0.020 |
Why?
|
| Confidence Intervals | 1 | 1997 | 2932 | 0.020 |
Why?
|
| Enteral Nutrition | 1 | 1997 | 785 | 0.020 |
Why?
|
| Middle Aged | 5 | 2024 | 220359 | 0.020 |
Why?
|
| Asthma | 2 | 2008 | 6172 | 0.020 |
Why?
|
| Follow-Up Studies | 6 | 2017 | 39262 | 0.020 |
Why?
|
| Drug Therapy, Combination | 1 | 2000 | 6498 | 0.020 |
Why?
|
| Antipsychotic Agents | 1 | 2003 | 3061 | 0.020 |
Why?
|
| Histamine H2 Antagonists | 2 | 2008 | 167 | 0.020 |
Why?
|
| Antibodies, Monoclonal | 1 | 2007 | 9185 | 0.020 |
Why?
|
| Risk Factors | 5 | 2012 | 74333 | 0.020 |
Why?
|
| Intention | 1 | 2012 | 345 | 0.020 |
Why?
|
| Liver | 2 | 2003 | 7510 | 0.020 |
Why?
|
| Mutation | 2 | 2018 | 29957 | 0.020 |
Why?
|
| Protein Multimerization | 1 | 2014 | 983 | 0.020 |
Why?
|
| Lipase | 1 | 1991 | 324 | 0.020 |
Why?
|
| Severity of Illness Index | 3 | 2002 | 15840 | 0.020 |
Why?
|
| Vascular Endothelial Growth Factors | 2 | 2001 | 748 | 0.020 |
Why?
|
| Diet Surveys | 1 | 2012 | 1161 | 0.020 |
Why?
|
| CD4 Lymphocyte Count | 1 | 2014 | 2569 | 0.020 |
Why?
|
| Hypertension | 2 | 1987 | 8595 | 0.020 |
Why?
|
| Defecation | 1 | 2009 | 190 | 0.020 |
Why?
|
| Acquired Immunodeficiency Syndrome | 1 | 1997 | 2197 | 0.020 |
Why?
|
| Age Factors | 2 | 2018 | 18413 | 0.020 |
Why?
|
| Immunologic Memory | 1 | 2014 | 1354 | 0.020 |
Why?
|
| Breath Tests | 2 | 1988 | 297 | 0.020 |
Why?
|
| Heterozygote | 1 | 2014 | 2798 | 0.020 |
Why?
|
| Age of Onset | 1 | 2014 | 3302 | 0.020 |
Why?
|
| Surgical Wound Infection | 1 | 1997 | 1527 | 0.020 |
Why?
|
| gamma-Glutamyltransferase | 1 | 1987 | 144 | 0.020 |
Why?
|
| Carbohydrate Metabolism | 1 | 1988 | 262 | 0.020 |
Why?
|
| Blood Loss, Surgical | 1 | 1991 | 656 | 0.020 |
Why?
|
| Focus Groups | 1 | 2012 | 1378 | 0.020 |
Why?
|
| Food Hypersensitivity | 1 | 1995 | 697 | 0.020 |
Why?
|
| Pancreas | 1 | 1994 | 1677 | 0.020 |
Why?
|
| Carbohydrates | 2 | 1988 | 388 | 0.020 |
Why?
|
| Transaminases | 1 | 1987 | 196 | 0.020 |
Why?
|
| Metoclopramide | 1 | 1986 | 51 | 0.020 |
Why?
|
| Dose-Response Relationship, Drug | 3 | 2007 | 10826 | 0.020 |
Why?
|
| Seasons | 1 | 2012 | 1522 | 0.020 |
Why?
|
| Interleukin-6 | 1 | 1996 | 3215 | 0.020 |
Why?
|
| Cohort Studies | 3 | 2018 | 41337 | 0.020 |
Why?
|
| DNA Mutational Analysis | 1 | 2014 | 4108 | 0.020 |
Why?
|
| Incidence | 2 | 1997 | 21391 | 0.020 |
Why?
|
| Cholestasis, Extrahepatic | 1 | 1985 | 51 | 0.020 |
Why?
|
| Treatment Outcome | 6 | 2017 | 64981 | 0.020 |
Why?
|
| Immunoglobulin G | 3 | 2004 | 4542 | 0.020 |
Why?
|
| Ureteral Obstruction | 1 | 1987 | 292 | 0.020 |
Why?
|
| Sweden | 1 | 2008 | 1381 | 0.020 |
Why?
|
| Phenylpropanolamine | 1 | 1985 | 15 | 0.020 |
Why?
|
| Chromatography, Gas | 1 | 1985 | 151 | 0.020 |
Why?
|
| Mutation, Missense | 1 | 2014 | 2567 | 0.020 |
Why?
|
| HEK293 Cells | 1 | 2014 | 4263 | 0.020 |
Why?
|
| Medicaid | 1 | 2018 | 2815 | 0.020 |
Why?
|
| Interviews as Topic | 1 | 2012 | 2659 | 0.020 |
Why?
|
| Hemolytic-Uremic Syndrome | 1 | 1985 | 106 | 0.020 |
Why?
|
| Fasting | 1 | 1991 | 1603 | 0.020 |
Why?
|
| Antibodies, Fungal | 1 | 2004 | 34 | 0.020 |
Why?
|
| Depression | 1 | 2004 | 8045 | 0.020 |
Why?
|
| Peptide Fragments | 2 | 1988 | 5132 | 0.010 |
Why?
|
| Receptor, IGF Type 2 | 1 | 1984 | 35 | 0.010 |
Why?
|
| Porins | 1 | 2004 | 79 | 0.010 |
Why?
|
| Hydrogen | 1 | 1985 | 171 | 0.010 |
Why?
|
| Electrophoresis, Agar Gel | 1 | 1984 | 217 | 0.010 |
Why?
|
| Vitamin D Deficiency | 1 | 1994 | 1379 | 0.010 |
Why?
|
| Bile Ducts | 1 | 1985 | 282 | 0.010 |
Why?
|
| Agammaglobulinemia | 1 | 1985 | 173 | 0.010 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2019 | 3985 | 0.010 |
Why?
|
| Parenteral Nutrition | 1 | 2008 | 656 | 0.010 |
Why?
|
| Pandemics | 1 | 2024 | 8623 | 0.010 |
Why?
|
| Twins | 1 | 1985 | 339 | 0.010 |
Why?
|
| Antibodies, Monoclonal, Murine-Derived | 1 | 2007 | 693 | 0.010 |
Why?
|
| Immunoglobulins | 1 | 2007 | 859 | 0.010 |
Why?
|
| Anti-Asthmatic Agents | 1 | 2008 | 565 | 0.010 |
Why?
|
| Twins, Monozygotic | 1 | 1985 | 469 | 0.010 |
Why?
|
| Naphthalenes | 1 | 1984 | 198 | 0.010 |
Why?
|
| Sequence Analysis, DNA | 1 | 2014 | 4716 | 0.010 |
Why?
|
| Proton Pump Inhibitors | 1 | 2008 | 551 | 0.010 |
Why?
|
| Medical Records | 1 | 2008 | 1407 | 0.010 |
Why?
|
| Proteins | 1 | 1998 | 6029 | 0.010 |
Why?
|
| Liver Transplantation | 1 | 1995 | 2325 | 0.010 |
Why?
|
| Motivation | 1 | 2012 | 1993 | 0.010 |
Why?
|
| Pheochromocytoma | 1 | 1985 | 328 | 0.010 |
Why?
|
| Antibodies, Antineutrophil Cytoplasmic | 1 | 2004 | 288 | 0.010 |
Why?
|
| Recurrence | 1 | 1995 | 8483 | 0.010 |
Why?
|
| Cricetulus | 1 | 1984 | 815 | 0.010 |
Why?
|
| Infusions, Intravenous | 1 | 2007 | 2235 | 0.010 |
Why?
|
| Oligosaccharides | 1 | 1984 | 405 | 0.010 |
Why?
|
| Chewing Gum | 1 | 1981 | 40 | 0.010 |
Why?
|
| Alkaline Phosphatase | 1 | 1984 | 865 | 0.010 |
Why?
|
| Hepatitis B Core Antigens | 1 | 1981 | 88 | 0.010 |
Why?
|
| Iodine Radioisotopes | 1 | 1984 | 1032 | 0.010 |
Why?
|
| Analysis of Variance | 2 | 2002 | 6238 | 0.010 |
Why?
|
| Cerebral Infarction | 1 | 1985 | 982 | 0.010 |
Why?
|
| Cricetinae | 1 | 1984 | 2427 | 0.010 |
Why?
|
| Internet | 1 | 2012 | 3078 | 0.010 |
Why?
|
| Aged, 80 and over | 2 | 2018 | 58980 | 0.010 |
Why?
|
| Phenotype | 1 | 2018 | 16548 | 0.010 |
Why?
|
| Diabetes Mellitus, Type 1 | 1 | 2014 | 3454 | 0.010 |
Why?
|
| Hepatitis B Surface Antigens | 1 | 1981 | 301 | 0.010 |
Why?
|
| Ovary | 1 | 1984 | 958 | 0.010 |
Why?
|
| Adrenal Gland Neoplasms | 1 | 1985 | 733 | 0.010 |
Why?
|
| Steroids | 1 | 2004 | 928 | 0.010 |
Why?
|
| Vascular Endothelial Growth Factor A | 2 | 2001 | 3484 | 0.010 |
Why?
|
| Histocompatibility Testing | 1 | 1981 | 717 | 0.010 |
Why?
|
| Adrenal Cortex Hormones | 1 | 1988 | 1869 | 0.010 |
Why?
|
| Recovery of Function | 1 | 2009 | 2985 | 0.010 |
Why?
|
| Rectum | 1 | 2004 | 895 | 0.010 |
Why?
|
| Drug Administration Schedule | 1 | 2007 | 4899 | 0.010 |
Why?
|
| CA-19-9 Antigen | 1 | 1999 | 106 | 0.010 |
Why?
|
| Drug Interactions | 1 | 2003 | 1428 | 0.010 |
Why?
|
| Cell Proliferation | 1 | 2014 | 10442 | 0.010 |
Why?
|
| Glycoconjugates | 1 | 1999 | 88 | 0.010 |
Why?
|
| Carbohydrate Sequence | 1 | 1999 | 410 | 0.010 |
Why?
|
| Osteomalacia | 1 | 1998 | 56 | 0.010 |
Why?
|
| Antibodies, Bacterial | 1 | 2004 | 1468 | 0.010 |
Why?
|
| Communication | 1 | 2012 | 3849 | 0.010 |
Why?
|
| Barium Sulfate | 2 | 1992 | 180 | 0.010 |
Why?
|
| Length of Stay | 1 | 1991 | 6476 | 0.010 |
Why?
|
| Benzodiazepines | 1 | 2003 | 1131 | 0.010 |
Why?
|
| Radioimmunoassay | 2 | 1989 | 865 | 0.010 |
Why?
|
| Quality of Life | 1 | 1999 | 13308 | 0.010 |
Why?
|
| Intestinal Fistula | 1 | 1997 | 143 | 0.010 |
Why?
|
| Probability | 1 | 2002 | 2475 | 0.010 |
Why?
|
| Models, Biological | 1 | 2012 | 9468 | 0.010 |
Why?
|
| Medical Audit | 1 | 1997 | 453 | 0.010 |
Why?
|
| Glycosylation | 1 | 1999 | 1096 | 0.010 |
Why?
|
| Infant Nutritional Physiological Phenomena | 1 | 1998 | 351 | 0.010 |
Why?
|
| Fibroblast Growth Factors | 1 | 2001 | 869 | 0.010 |
Why?
|
| Immunity, Mucosal | 1 | 1999 | 481 | 0.010 |
Why?
|
| Cholesterol | 1 | 1984 | 2924 | 0.010 |
Why?
|
| Skin | 1 | 2008 | 4466 | 0.010 |
Why?
|
| Regression Analysis | 1 | 2004 | 6359 | 0.010 |
Why?
|
| Cholesterol, LDL | 1 | 1984 | 2420 | 0.010 |
Why?
|
| Heart Arrest | 1 | 1985 | 1506 | 0.010 |
Why?
|
| Solubility | 1 | 1996 | 1088 | 0.010 |
Why?
|
| Neoplasms, Multiple Primary | 1 | 1998 | 586 | 0.010 |
Why?
|
| Longitudinal Studies | 2 | 2007 | 14494 | 0.010 |
Why?
|
| Eosinophils | 1 | 1999 | 944 | 0.010 |
Why?
|
| Sex Characteristics | 1 | 2004 | 2629 | 0.010 |
Why?
|
| Chronic Disease | 2 | 1988 | 9288 | 0.010 |
Why?
|
| Saccharomyces cerevisiae | 1 | 2004 | 2698 | 0.010 |
Why?
|
| B-Lymphocytes | 1 | 2007 | 4742 | 0.010 |
Why?
|
| Health Status Indicators | 1 | 1999 | 968 | 0.010 |
Why?
|
| Combined Modality Therapy | 2 | 1996 | 8552 | 0.010 |
Why?
|
| Databases, Factual | 1 | 2008 | 8022 | 0.010 |
Why?
|
| Lidocaine | 1 | 1996 | 538 | 0.010 |
Why?
|
| Aged | 2 | 2018 | 169143 | 0.010 |
Why?
|
| Escherichia coli | 1 | 2004 | 4219 | 0.010 |
Why?
|
| Cross-Sectional Studies | 2 | 2004 | 25941 | 0.010 |
Why?
|
| Time Factors | 2 | 1991 | 40139 | 0.010 |
Why?
|
| Monitoring, Physiologic | 1 | 1999 | 1784 | 0.010 |
Why?
|
| Atrophy | 1 | 1996 | 1626 | 0.010 |
Why?
|
| Carrier Proteins | 1 | 1984 | 4938 | 0.010 |
Why?
|
| Gastrointestinal Neoplasms | 1 | 1998 | 951 | 0.010 |
Why?
|
| Cell Line | 1 | 1984 | 15620 | 0.010 |
Why?
|
| Leptin | 1 | 1998 | 1590 | 0.010 |
Why?
|
| United States Food and Drug Administration | 1 | 1998 | 1677 | 0.010 |
Why?
|
| Dietary Proteins | 1 | 1995 | 949 | 0.010 |
Why?
|
| Antibodies, Viral | 1 | 1981 | 3142 | 0.010 |
Why?
|
| Pregnancy | 2 | 2008 | 29746 | 0.010 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 1984 | 3332 | 0.010 |
Why?
|
| Patient Satisfaction | 1 | 2002 | 3448 | 0.010 |
Why?
|
| Sorbitol | 1 | 1988 | 56 | 0.000 |
Why?
|
| Pilot Projects | 1 | 2002 | 8556 | 0.000 |
Why?
|
| Cells, Cultured | 1 | 1984 | 18955 | 0.000 |
Why?
|
| Substance-Related Disorders | 1 | 1985 | 4371 | 0.000 |
Why?
|
| Administration, Oral | 1 | 1996 | 4035 | 0.000 |
Why?
|
| Sucrose | 1 | 1988 | 156 | 0.000 |
Why?
|
| Neoplasms | 1 | 1997 | 22075 | 0.000 |
Why?
|
| Chemotherapy, Adjuvant | 1 | 1996 | 3530 | 0.000 |
Why?
|
| Logistic Models | 1 | 2002 | 13312 | 0.000 |
Why?
|
| Fructose | 1 | 1988 | 287 | 0.000 |
Why?
|
| Molecular Sequence Data | 1 | 1999 | 17624 | 0.000 |
Why?
|
| Health Policy | 1 | 1998 | 2677 | 0.000 |
Why?
|
| Reoviridae Infections | 1 | 1985 | 59 | 0.000 |
Why?
|
| Gastric Lavage | 1 | 1985 | 17 | 0.000 |
Why?
|
| Sodium Pertechnetate Tc 99m | 1 | 1985 | 55 | 0.000 |
Why?
|
| Technetium Tc 99m Sulfur Colloid | 1 | 1985 | 63 | 0.000 |
Why?
|
| Epilepsy, Tonic-Clonic | 1 | 1985 | 53 | 0.000 |
Why?
|
| Hemiplegia | 1 | 1985 | 136 | 0.000 |
Why?
|
| Peptic Ulcer Hemorrhage | 1 | 1985 | 47 | 0.000 |
Why?
|
| Enema | 1 | 1985 | 141 | 0.000 |
Why?
|
| Digestive System | 1 | 1985 | 244 | 0.000 |
Why?
|
| Hemostatic Techniques | 1 | 1985 | 114 | 0.000 |
Why?
|
| Case-Control Studies | 1 | 2001 | 22052 | 0.000 |
Why?
|
| Serologic Tests | 1 | 1985 | 383 | 0.000 |
Why?
|
| Serum Albumin | 1 | 1985 | 674 | 0.000 |
Why?
|
| Disease Progression | 1 | 1999 | 13505 | 0.000 |
Why?
|
| Radionuclide Imaging | 1 | 1985 | 1975 | 0.000 |
Why?
|
| Immunoglobulin M | 1 | 1985 | 1529 | 0.000 |
Why?
|
| Radiography | 1 | 1992 | 6965 | 0.000 |
Why?
|
| Body Mass Index | 1 | 1998 | 12914 | 0.000 |
Why?
|
| Angiography | 1 | 1985 | 1605 | 0.000 |
Why?
|
| Bacterial Infections | 1 | 1985 | 1403 | 0.000 |
Why?
|
| Glucose | 1 | 1988 | 4350 | 0.000 |
Why?
|
| Animals | 1 | 1984 | 167960 | 0.000 |
Why?
|
| Diagnosis, Differential | 1 | 1985 | 12968 | 0.000 |
Why?
|
| Magnetic Resonance Imaging | 1 | 1996 | 36286 | 0.000 |
Why?
|
| Tomography, X-Ray Computed | 1 | 1985 | 20509 | 0.000 |
Why?
|